Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
The transition to a survivorship program evokes complex emotions, including excitement, hesitation, and survivor's guilt, as ...
Despite its popularity, biotin lacks strong evidence for hair regrowth, and safer alternatives like minoxidil are recommended ...
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
Obeid emphasized that risk assessment is a critical part of ongoing cancer care. It helps patients and their families understand the cancer’s causes, informs treatment options and supports strategies ...
Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...
Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.
Caregivers can neglect routine medical care, such as attending doctor’s appointments, getting screenings, taking medications, ...
Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did ...
The FDA has granted fast track designation to LBL-034 for patients with relapsed or refractory multiple myeloma. The U.S.
Breast cancer survivors face increased skin cancer risk, necessitating regular dermatological check-ups and self-examinations ...
The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results